MedTrace Logo

Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

NCT03060694 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2018-05-11

No results posted yet for this study

Summary

The purpose of this study is to compare the severity of NAFLD in diabetic patients to that in non-diabetic patients.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

OTHER

diabetes

1. a history of diabetes and using anti-diabetic medicines. 2. fasting serum glucose level greater than 7.1mmol/L, or glycosylated hemoglobin percentage greater than 6.5%.

Sponsors & Collaborators

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Zhengjie Xu, MD · Xinhua Hospital, Shanghai Jiaotong Univerisity School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-02-28
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060694 on ClinicalTrials.gov